Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 42.89
- Piotroski Score 3.00
- Grade Hold
- Symbol (DICE)
- Company DICE Therapeutics, Inc.
- Price $47.55
- Changes Percentage (0.06%)
- Change $0.03
- Day Low $47.46
- Day High $47.83
- Year High $47.90
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lead therapeutic candidate is DC-806, an oral antagonist of the pro-inflammatory signaling molecule, interleukin-17, which is a validated drug target implicated in a various immunology indications. It is also developing oral therapeutic candidates targeting a4ß7 integrin for the treatment of inflammatory bowel diseases, as well as targeting aVß1/aVß6 integrin for the treatment of idiopathic pulmonary fibrosis. In addition, the company focuses on immuno-oncology for antibody therapeutics. The company was incorporated in 2013 and is headquartered in South San Francisco, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/09/2023
- Fiscal Year End N/A
- Average Stock Price Target $60.00
- High Stock Price Target $60.00
- Low Stock Price Target $60.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$2.17
- Trailing P/E Ratio -21.912442396313
- Forward P/E Ratio -21.912442396313
- P/E Growth -21.912442396313
- Net Income $-81,664,000
Income Statement
Quarterly
Annual
Latest News of DICE
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Lions weigh up rolling dice on Las Vegas fixture for 2029 New Zealand tour
The British & Irish Lions are considering playing a fixture in Las Vegas during their 2029 tour of New Zealand, with possibilities in Los Angeles or Japan. All Blacks are looking to expand commercial ...
By The Guardian | 20 hours ago -
Teresa Giudice Gets Her Lip Filler Dissolved for a More 'Natural' Look: See the Before and After
Teresa Giudice underwent a lip filler removal procedure to achieve a more natural look, sharing the process on TikTok. She plans to reinject her lips for a plump look. This transparency about cosmetic...
By PEOPLE.com | 3 days ago -
Marty Baron on Post endorsement choice: 'This is cowardice'
Former Washington Post editor Marty Baron criticized the publication for deciding not to endorse a presidential candidate, calling it "cowardice." The paper broke a 36-year tradition and faced backlas...
By The Hill | 1 week ago
